INTRODUCTION
Type 1 neurofibromatosis (NF1) is an autosomal dominant genetic disorder caused by biallelic suppression of the NF1 tumor suppressor gene, located on chromosome 17.It occurs in 1/3,500 individuals and carries a 3%-15% mortality rate. [3, 8] NF1 occurs in all races, and some report a small female preponderance. [1, 2, 5] Only 2% of patients with NF1 have symptomatic spinal tumors.
CASE REPORT
A 38-year-old male presented with a 4-year history of cervicalgia, dysphagia/mild dysphonia, gait alteration, and progressive hypoesthesia of all four extremities. e patient had a history of type I NF1 diagnosed 20 years previously. On examination, the patient exhibited cutaneous nodules/café-au-lait spots scoliosis, and a Grade 4 tetraparesis characterized by diffuse hyperreflexia with bilateral Babinski signs [ Figure 1 ].
Radiographic analysis
e cervical magnetic resonance imaging (MRI) demonstrated a solid, nodular, expansive lesion originating at the C2-C3 (5 cm × 4 cm × 5.1 cm) level with extension toward the foramen magnum. It contributed to medullary and bulbar compression [ Figure 2 ]. A secondary lesion was visualized at the C4-C5 level on the right.
Surgical intervention
e surgical approach included a right lateral suboccipital craniectomy, removal of the posterior C1 arch, and C2 laminectomy for resection of the dumbbell C2-C3 lesion. is was accompanied by a right C4-C5 hemilaminectomy for excision of the secondary tumor. Gross total lesion resection of the C2-C3 dumbell neurofibroma was accomplished. Partial removal of the C4-C5 secondary lesion was performed as this was benign, and it allowed for the preservation of stability [ Figure 3 ]. Somatosensory evoked potential and motor evoked potential monitoring did not change during the procedure. Postoperatively, the patient's tetraparesis progressively improved and hypoesthesia resolved. e postoperative magnetic resonance (MR) scan obtained revealed satisfactory resection of both lesions [ Figure 4 ]. 
DISCUSSION
Genetic transmission or spontaneous mutation NF1 may either be genetically inherited (e.g., autosomal dominant) or, more frequently, may occur as a new mutation. e NF1 gene encodes a protein called neurofibromin, which is a tumor suppressor. Changes in expression of the NF1 gene contribute to tumorigenesis and the formation of neurofibromas. ey develop around the peripheral nerves, often manifesting as encapsulated masses, and are localized in the dermal and/or subcutaneous tissues. Others may present as plexiform neurofibromas involving peripheral nerve roots. [4] Varied phenotypes NF1 tumors present with varied clinical phenotypes characterized by; café-au-lait spots (95% single/multiple skin lesions) and neurofibromas. [3, 6] Plexiform neurofibromas occur in 30% of patients who present with multiple neurofibromas, diffusely involving peripheral nerves. Of the paraspinal neurofibromas, 72% are intradural and extramedullary and 14% are only extradural, while 13% are dumbbell lesions. [3] 
Clinical presentation
With NF1, spinal tumors are occur 40% of the time. Notably, only 2% are symptomatic, often correlated with progressive quadriparesis, along with neck pain and urinary incontinence. Here, the patient had MR-documented medullary compression invading the prebulbar cistern attributed to the C2C3 lesion, plus a secondary C4-C5 tumor contributing to right-sided cord compression.
MR findings of neurofibromatosis 1 lesions
NF1 findings on MRI, as in this case, include iso or hyperintensity on T1, hyperintensity on T2, and homogeneous enhancement with gadolinium of T1 images. [4] Pathological/histological and immunohistochemistry findings with neurofibromatosis 1 tumors Microscopically, NF1 lesions are comprised of Schwann cells, fibroblasts, and perineural cells which typically permeate between/separate the axons from the nerves. e immunohistochemistry commonly shows; S100 positive and EMA negative. Here, the pathological and immunohistochemical results confirmed the diagnosis of NF1; positive immunohistochemistry for CD34, S100 protein, and Ki67, EMA negative, and positive neurofilaments in the intervening axons.
Surgical approach and risks
ere are multiple surgical options for dealing with NF1 lesions depending on their spinal location and size. George and Lot proposed a classification system for extramedullary foramen magnum tumors. [7] e anterior lesions were bilateral or unilateral; the lateral lesions were located between midline and dentate ligament and the posterior lesions behind dentate ligament. [7] Here, one of the biggest challenges with cervical tumors is the relationship with the vertebral artery (VA) that can be displaced and compressed by the tumor. erefore, preoperative angiography may be warranted. George and Lot noted the lateral approach (anterolateral and posterolateral) provided the best results versus a standard posterior approach due to the better clinical results and complete lesion ressection. e standard posterior approach is most effective when there the tumor is not adherent to the cord.
Purely extradural tumors anterior to the VA necessitate an anterolateral approach, while most cervical dumbbell warrants a posterolateral approach.
Here, we chose to perform a lateral suboccipital craniectomy, which facilitated identification and dissection away from the VA. e posterior C1 arch was removed, and the C2 laminectomy was performed to achieve complete removal of the C2-C3 lesion. is was followed by a right-sided C4-C5 hemilaminectomy for partial resection of the second C4-C5 lesion (e.g., only partial facet removal to preserve stability).
CONCLUSIONS
In a patient with NF1 who presented with dysphagia/dysphonia and tetraparesis, we removed a giant C2-C3 plexiform/dumbbell neurofibroma extending into the foramen magnum/prebulbar cistern along with a secondary right-sided C5 lesion.
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